WallStreetZenWallStreetZen

NASDAQ: FULC
Fulcrum Therapeutics Inc Stock Ownership - Who owns Fulcrum Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Fulcrum Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert J. GouldDirector2026-02-0215,000$10.72
$160.86kSell
Robert J. GouldDirector2026-01-0215,000$11.87
$178.10kSell
Robert J. GouldDirector2026-01-0215,000$10.87
$163.10kSell
Curtis Gale OltmansChief Legal Officer2025-12-153,452$12.92
$44.60kSell
Ra Capital Management LP10% Owner2025-12-0891,722$14.98
$1.37MSell
Ra Capital Management LP10% Owner2025-12-081,377,020$13.33
$18.36MSell
Ra Capital Management LP10% Owner2025-12-082,706,397$14.28
$38.65MSell
Robert J. GouldDirector2025-11-1915,000$11.03
$165.50kSell
Greg TourangeauPrincipal Accounting Officer2025-05-08498$5.06
$2.52kSell

1 of 1

FULC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FULC insiders and whales buy or sell their stock.

FULC Shareholders

What type of owners hold Fulcrum Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP24.12%13,053,960$143.59MInsider
Suvretta Capital Management LLC12.12%6,561,111$72.17MInstitution
Ra Capital Management LP11.19%6,053,960$66.59MInstitution
Mark J. Levin11.17%6,046,425$66.51MInsider
Tcg Crossover Management LLC9.70%5,250,000$57.75MInstitution
Nantahala Capital Management LLC7.93%4,293,346$47.23MInstitution
Blackrock Inc7.88%4,263,761$46.90MInstitution
Vanguard Group Inc6.58%3,559,552$39.16MInstitution
Braidwell LP5.66%3,061,222$33.67MInstitution
Third Rock Ventures III LP4.62%2,499,343$27.49MInsider

1 of 3

FULC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FULC69.99%30.01%Net SellingNet Selling
SLS24.82%6.55%Net SellingNet Selling
LBRX76.06%23.94%Net Buying
MGTX57.68%42.32%Net SellingNet Selling
PRME45.73%54.27%Net Buying
View Top Biotech Stocks

Fulcrum Therapeutics Stock Ownership FAQ

Who owns Fulcrum Therapeutics?

Fulcrum Therapeutics (NASDAQ: FULC) is owned by 124.55% institutional shareholders, 53.39% Fulcrum Therapeutics insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual Fulcrum Therapeutics shareholder, owning 13.05M shares representing 24.12% of the company. Ra Capital Management LP's Fulcrum Therapeutics shares are currently valued at $143.59M.

If you're new to stock investing, here's how to buy Fulcrum Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.